fda removes tirzepatide from shortage list As of February 21, 2025, the updated its drug list, marking the semaglutide injection shortage as resolved. Semaglutide injections are no longer classified as “currently in shortage,” and both 503A Article » Proact Pharmacy Services

Many of its products include testing documentation such as Certificates of Analysis and purity reports

20 An accumulative effect, stronger with chronic treatment, cannot be excluded

But the shape, the accumulation pattern, the relative timing of peaks and troughs, these remain accurate enough to guide practical decisions

COVERAGE OUTLOOK What's Changing in 2026 2026: Diverging Trends The insurance landscape for Zepbound is splitting: Medicare/Medicaid expanding via new CMS pilot programs while many commercial plans are pulling back

Confirmation the patient is not receiving PBS-subsidised SGLT2-i, DPP-4 i, or another GLP-1 RA.

Fontes-Dutra M, Santos-Terra J, Deckmann I, Brum Schwingel G, Della-Flora Nunes G, Hirsch MM, Bauer-Negrini G, Riesgo RS, Bambini-Jnior V, Hedin-Pereira C, Gottfried C